Cargando…
Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis
BACKGROUND: Most patients with moderate and severe chronic obstructive pulmonary disease (COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however, unclear if and what drug treatments should be added to LABAs to reduce exacerbations, which is an important goal of COPD man...
Autores principales: | Mills, Edward J, Druyts, Eric, Ghement, Isabella, Puhan, Milo A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072154/ https://www.ncbi.nlm.nih.gov/pubmed/21487451 http://dx.doi.org/10.2147/CLEP.S16235 |
Ejemplares similares
-
Multiple treatment comparison meta-analyses: a step forward into complexity
por: Mills, Edward J, et al.
Publicado: (2011) -
Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison
por: O'Regan, Christopher, et al.
Publicado: (2009) -
The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD
por: Thorlund, Kristian, et al.
Publicado: (2014) -
Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection
por: Druyts, Eric, et al.
Publicado: (2013) -
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
por: Puhan, Milo A, et al.
Publicado: (2009)